Tom Harvey
Myriad Genetics continues to fight SCOTUS ruling on gene patents
Since the Supreme Court invalidated parts of its patents on breast cancer genes in June, Myriad Genetics has been fighting ...
Myriad argues (again) for patents related to breast cancer genes
Before a courtroom packed Wednesday with attorneys and company officials, Utah-based Myriad Genetics again defended its patents related to genes ...